Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Spencer

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Drugs|August 26, 1998
Enoxaparin. A review of its clinical potential in the management of coronary artery diseaseS Noble, C M Spencer
Drugs|August 10, 1999
Entacapone. A review of its use in Parkinson's diseaseK J Holm, C M Spencer
Pharmacoeconomics|March 9, 1995
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infectionsC M Spencer, H M Bryson
Drugs|March 1, 1997
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infectionsR N Brogden, C M Spencer
Drugs|October 20, 1998
LevobupivacaineK J McClellan, C M Spencer
Drugs|October 20, 1998
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapyL R Wiseman, C M Spencer
Drugs|January 1, 1996
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infectionsS S Patel, C M Spencer
Drugs|September 1, 1996
RemifentanilS S Patel, C M Spencer
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant Factor VIIaC J Dunn, C M Spencer
Drugs|August 10, 2000
Ropinirole: a review of its use in the management of Parkinson's diseaseA J Matheson, C M Spencer
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Drugs|August 26, 1998
Enoxaparin. A review of its clinical potential in the management of coronary artery diseaseS Noble, C M Spencer
Drugs|August 10, 1999
Entacapone. A review of its use in Parkinson's diseaseK J Holm, C M Spencer
Pharmacoeconomics|March 9, 1995
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infectionsC M Spencer, H M Bryson
Drugs|March 1, 1997
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infectionsR N Brogden, C M Spencer
Drugs|October 20, 1998
LevobupivacaineK J McClellan, C M Spencer
Drugs|October 20, 1998
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapyL R Wiseman, C M Spencer
Drugs|January 1, 1996
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infectionsS S Patel, C M Spencer
Drugs|September 1, 1996
RemifentanilS S Patel, C M Spencer
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant Factor VIIaC J Dunn, C M Spencer
Drugs|August 10, 2000
Ropinirole: a review of its use in the management of Parkinson's diseaseA J Matheson, C M Spencer
Pageof 8